Skip to main navigation Skip to search Skip to main content

Design and synthesis of new antagonist peptides for platelet GPIIb/IIIa receptor as anti-thrombotic agents

  • Yoshio Hayashi
  • , Yoshimi Sato
  • , Jun Katada
  • , Yoshimi Takiguchi
  • , Iwao Ojima
  • , Isao Uno
  • Nippon Steel Corporation

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

The structure-activity relationships of N-terminal modified RGD peptides against platelet aggregation inhibitory activity were studied, and Orotyl- Ser-Arg-Gly-Asp-Trp (NSL-9403) was found to be a new and effective anti- thrombotic agent during extracorporeal circulation.

Original languageEnglish
Pages (from-to)1351-1356
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume6
Issue number12
DOIs
StatePublished - Jun 18 1996

Fingerprint

Dive into the research topics of 'Design and synthesis of new antagonist peptides for platelet GPIIb/IIIa receptor as anti-thrombotic agents'. Together they form a unique fingerprint.

Cite this